genosmart DX results: What to expect

By ordering our analysis, you will get an annotated list of variants in your tumor or plasma samples. The analysis is focuses only on the set of genes or parts of genes included in the given gene panel. We indicate if there is a known personalized therapy based on the detected variants, but only an oncologist expert can fully interpret the results and determine the optimal therapy.

Highlighted genes: This is a list of the most relevant genes and their mutational status in the case of the given tumor sample.

Clinically relevant mutations: We report here all variants with known phenotypical consequences.

Genetic alterations with therapeutic consequences: We report here all variants with known therapeutic consequences, according to FDA implications or scientific literature. We report all known drug cross-reactions as well as sensitivity enhancements.

Late-stage clinical trials in relation with the molecular alterations: We search all relevant databases for running clinical trials and report all late-stage trials.

Interpretation of the results: We provide all the relevant technical data about the sequencing and analysis; we report if there is any limitation of the analysis.

Appendix: We report all variants above “clinically neutral” or “most likely neutral”.